Phage therapy for severe bacterial infections: a narrative review
Open Access
- 6 October 2019
- journal article
- review article
- Published by Wiley in Medical Journal of Australia
- Vol. 212 (6) , 279-285
Abstract
Bacteriophage (phage) therapy is re‐emerging a century after it began. Activity against antibiotic‐resistant pathogens and a lack of serious side effects make phage therapy an attractive treatmen...Keywords
Funding Information
- National Health and Medical Research Council (1104232, 1107322)
This publication has 63 references indexed in Scilit:
- Phage Therapy: Concept to CureFrontiers in Microbiology, 2012
- Phage treatment of human infectionsBacteriophage, 2011
- Phages in natureBacteriophage, 2011
- The perspectives of the application of phage therapy in chronic bacterial prostatitisFEMS Immunology & Medical Microbiology, 2010
- Kinetics of Phage-Mediated Biocontrol of BacteriaFoodborne Pathogens and Disease, 2009
- A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic‐resistant Pseudomonas aeruginosa; a preliminary report of efficacyClinical Otolaryngology, 2009
- Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical TrialsPLOS ONE, 2009
- T-even-related bacteriophages as candidates for treatment of Escherichia coli urinary tract infectionsArchives of Virology, 2008
- Ecology of prokaryotic virusesFEMS Microbiology Reviews, 2004
- Pharmacokinetic Principles of Bacteriophage TherapyClinical Pharmacokinetics, 2003